Holst A - Search Results

Year	Number of Results
1902	1
1907	4
1975	1
1976	6
1977	4
1978	1
1979	1
1981	1
1982	1
1983	2
1984	1
1985	1
1987	4
1988	6
1989	1
1990	2
1992	6
1993	3
1994	1
1995	2
1996	2
1997	2
1998	4
1999	2
2003	1
2004	2
2006	2
2007	3
2008	6
2009	10
2010	14
2011	16
2012	16
2013	17
2014	12
2015	10
2016	7
2017	11
2018	12
2019	15
2020	13
2021	10
2022	12
2023	9
2024	9

1

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design.

Ryan DH, Lingvay I, Colhoun HM, Deanfield J, Emerson SS, Kahn SE, Kushner RF, Marso S, Plutzky J, Brown-Frandsen K, Gronning MOL, Hovingh GK, Holst AG, Ravn H, Lincoff AM. Ryan DH, et al. Among authors: holst ag. Am Heart J. 2020 Nov;229:61-69. doi: 10.1016/j.ahj.2020.07.008. Epub 2020 Jul 17. Am Heart J. 2020. PMID: 32916609 Free article.

2

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. Among authors: holst ag. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.

3

Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.

Svendsen JH, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Kronborg C, Olesen MS, Nielsen JB, Holst AG, Brandes A, Haugan KJ, Køber L. Svendsen JH, et al. Among authors: holst ag. Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469766

4

Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.

Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, Herron TJ, McCarthy S, Schmidt EM, Sveinbjornsson G, Surakka I, Mathis MR, Yamazaki M, Crawford RD, Gabrielsen ME, Skogholt AH, Holmen OL, Lin M, Wolford BN, Dey R, Dalen H, Sulem P, Chung JH, Backman JD, Arnar DO, Thorsteinsdottir U, Baras A, O'Dushlaine C, Holst AG, Wen X, Hornsby W, Dewey FE, Boehnke M, Kheterpal S, Mukherjee B, Lee S, Kang HM, Holm H, Kitzman J, Shavit JA, Jalife J, Brummett CM, Teslovich TM, Carey DJ, Gudbjartsson DF, Stefansson K, Abecasis GR, Hveem K, Willer CJ. Nielsen JB, et al. Among authors: holst ag. Nat Genet. 2018 Sep;50(9):1234-1239. doi: 10.1038/s41588-018-0171-3. Epub 2018 Jul 30. Nat Genet. 2018. PMID: 30061737 Free PMC article.

5

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR. Ahmann AJ, et al. Among authors: holst ag. Diabetes Care. 2018 Feb;41(2):258-266. doi: 10.2337/dc17-0417. Epub 2017 Dec 15. Diabetes Care. 2018. PMID: 29246950 Clinical Trial.

6

A ubiquitous mobile genetic element disarms a bacterial antagonist of the gut microbiota.

Sheahan ML, Coyne MJ, Flores K, Garcia-Bayona L, Chatzidaki-Livanis M, Sundararajan A, Holst AQ, Barquera B, Comstock LE. Sheahan ML, et al. Among authors: holst aq. bioRxiv [Preprint]. 2023 Aug 26:2023.08.25.553775. doi: 10.1101/2023.08.25.553775. bioRxiv. 2023. PMID: 37662397 Free PMC article. Preprint.

7

New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.

Andreasen C, Nielsen JB, Refsgaard L, Holst AG, Christensen AH, Andreasen L, Sajadieh A, Haunsø S, Svendsen JH, Olesen MS. Andreasen C, et al. Among authors: holst ag. Eur J Hum Genet. 2013 Sep;21(9):918-28. doi: 10.1038/ejhg.2012.283. Epub 2013 Jan 9. Eur J Hum Genet. 2013. PMID: 23299917 Free PMC article.

8

Clustering identifies endotypes of traumatic brain injury in an intensive care cohort: a CENTER-TBI study.

Åkerlund CAI, Holst A, Stocchetti N, Steyerberg EW, Menon DK, Ercole A, Nelson DW; CENTER-TBI Participants and Investigators. Åkerlund CAI, et al. Among authors: holst a. Crit Care. 2022 Jul 27;26(1):228. doi: 10.1186/s13054-022-04079-w. Crit Care. 2022. PMID: 35897070 Free PMC article. Clinical Trial.

9

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.

Ahrén B, Atkin SL, Charpentier G, Warren ML, Wilding JPH, Birch S, Holst AG, Leiter LA. Ahrén B, et al. Among authors: holst ag. Diabetes Obes Metab. 2018 Sep;20(9):2210-2219. doi: 10.1111/dom.13353. Epub 2018 Jun 12. Diabetes Obes Metab. 2018. PMID: 29766634 Free PMC article. Clinical Trial.

10

A higher order Bayesian neural network with spiking units.

Lansner A, Holst A. Lansner A, et al. Among authors: holst a. Int J Neural Syst. 1996 May;7(2):115-28. doi: 10.1142/s0129065796000816. Int J Neural Syst. 1996. PMID: 8823623 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

239 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year